PPT for Finasteride Market

1
Finasteride Market 2016 2024
Finasteride Market Size, Industry Analysis
Report, Regional Outlook, Application Development
Potential, Price Trend, Competitive Market Share
Forecast, 2016 2024
2
Global Market Scenario of Finasteride

• Finasteride Market addresses hair loss, brought
  about by change in consumer eating habits,
  sedentary lifestyle and rise in stress levels. 
• Global alopecia (hair loss treatment) market was
  worth over USD 7 billion in 2015 and may surpass
  USD 11 billion valuation by 2024. Finasteride,
  being the solely oral medication approved by FDA
  for male hair loss treatment have an upper hand
  in alopecia market growth.
• Oral drugs market valuation was over USD 500
  million in 2015and may exceed USD 990 million by
  2024. 
• Blocking the male hormone testosterone and
  conversion into androgen dihydrotestosterone
  (DHT), which is responsible for hair loss is
  intrinsic property responsible for global
  finasteride market size growth.

3
Continue.....

• As per American Hair Loss Association, globally
  approximately 750 thousand people are engaged in
  hair loss treatment and androgenetic alopecia
  accounted for more than 90 of hair loss among
  men in 2015. 
• Coronary heart disease and prostate enlargement
  are primary reasons to cause this male pattern
  baldness. Moreover, prostate cancer, diabetes
  obesity, and high blood pressure are other
  responsible factors to lead men hair loss.
• Pilot projects conducted by European Urology to
  screen trial for bladder cancer risk reduction in
  men from the prostate, colon, and lung, who used
  finasteride are positive indicators for product
  being host of multiple applications. 
• Get more detail _at_ https//www.gminsights.com/indus
  try-analysis/finasteride-market

4
360 Analysis

• Application Analysis
• Major application includes treatment of benign
  prostatic hyperplasia (BPH), male pattern
  baldness, hormone replacement therapy. The
  product is demonstrated effective in men it has
  contrary effects on female and children thus it
  is recommended to be not in touch with the
  medicine. In BPH, the prostate gland becomes
  larger in older men which causes problems with
  passing urine as it is situated near bladder.
• Regional Analysis
• U.S. finasteride market size may witness
  significant gains owing to its global dominance
  in alopecia treatment industry. North America
  generated over 2 billion revenue in alopecia
  market in 2015. Government approval to use
  finasteride in men hair loss treatment and other
  health problems accompanied by better results
  from other alternatives are influencing factors
  to foster regional growth.
• Competitive Market Share
• Finasteride market share comprises of Merck Sharp
  Dohme, Sun Pharmaceuticals, Ranbaxy
  Laboratories, Dr. Reddys Laboratories and Intas
  Pharmaceuticals. Other prominent companies
  include Aurobindo Pharma, Teva Pharmaceuticals,
  Actavis, Hetero Labs, Yabao Pharmaceuticals,
  Cipla, Yangtze River Pharma, Gedeon Richter,
  Nanjing Sanhome, Shandong Renhetang Hangzhou
  Conba Group, New Asia Pharma, and Qianjin Pharma.

5

Request for an in-depth table of contents for
this report _at_ http//bit.ly/2bPuLle Browse
complete summary of this report _at_
http//bit.ly/2cbJ5di
6
Stay In Touch You can visit us at
www.gminsights.com